FRANKFURT (Reuters) -Swiss drugmaker Roche has abandoned global targets for a more diverse workforce to avoid penalties from ...

The foundations and strategies behind these Top 10 Best Japanese logos offer invaluable lessons for designers worldwide. Follow to learn more. Logos are more than simple graphic marks – they visually ...

A free, open-source tool for creating animated logos with a liquid metal aesthetic. Create logo animations in real-time in the browser.

Ash Wednesday marks the beginning of Lent for people of Christian faith. Each year, Catholics, Lutherans and other denominations around the world observe the 40-day period of self-sacrifice and ...

Logos are powerful branding tools that can leave an indelible impression in our minds. But what explains why some iconic logos, like the Nike swoosh or McDonald's golden arches, stick in our memory ...

Pope Francis is thanking Catholics around the world for their prayers as he continues battling double pneumonia in a Rome hospital where he remains in critical condition as of Feb. 23. "I have ...

UBS analyst Matthew Weston maintained a Buy rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of CHF338.00. The company’s shares closed yesterday at $324.00.

Roche’s innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...

Roche Global Media Relations Phone: +41 61 688 8888 / e-mail: [email protected] Hans Trees, PhD Phone: +41 79 407 72 58 Sileia Urech Phone: +41 79 935 81 48 ...

Roche (RHHBY) unveiled its proprietary, breakthrough sequencing by expansion technology, establishing a new category of next-generation sequencing. SBX chemistry, combined with an innovative ...

“When is the last time the country was able to solve any of its problems?” ambitious congresswoman Alexandra Mullen (Lizzy Caplan) screams at her father and former POTUS George Mullen (Robert ...

NEW YORK – With the launch of two point-of-care molecular assays for sexually transmitted infections, Roche Diagnostics is preparing to enter a new commercial market. The assays run on the firm's ...